Serological reconstruction of COVID-19 epidemics through analysis of antibody kinetics to SARS-CoV-2 proteins
Preprint
- 8 March 2021
- preprint
- Published by Cold Spring Harbor Laboratory
Abstract
Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces a complex antibody response that varies by orders of magnitude between individuals and over time. Waning antibody levels lead to reduced sensitivity of serological diagnostic tests over time. This undermines the utility of serological surveillance as the SARS-CoV-2 pandemic progresses into its second year. Here we develop a multiplex serological test for measuring antibodies of three isotypes (IgG, IgM, IgA) to five SARS-CoV-2 antigens (Spike (S), receptor binding domain (RBD), Nucleocapsid (N), Spike subunit 2, Membrane-Envelope fusion) and the Spike proteins of four seasonal coronaviruses. We measure antibody responses in several cohorts of French and Irish hospitalized patients and healthcare workers followed for up to eleven months after symptom onset. The data are analysed with a mathematical model of antibody kinetics to quantify the duration of antibody responses accounting for inter-individual variation. One year after symptoms, we estimate that 36% (95% range: 11%, 94%) of anti-S IgG remains, 31% (9%, 89%) anti-RBD IgG remains, and 7% (1%, 31%) anti-N IgG remains. Antibodies of the IgM isotype waned more rapidly, with 9% (2%, 32%) anti-RBD IgM remaining after one year. Antibodies of the IgA isotype also waned rapidly, with 10% (3%, 38%) anti-RBD IgA remaining after one year. Quantitative measurements of antibody responses were used to train machine learning algorithms for classification of previous infection and estimation of time since infection. The resulting diagnostic test classified previous infections with 99% specificity and 98% (95% confidence interval: 94%, 99%) sensitivity, with no evidence for declining sensitivity over the time scale considered. The diagnostic test also provided accurate classification of time since infection into intervals of 0 – 3 months, 3 – 6 months, and 6 – 12 months. Finally, we present a computational method for serological reconstruction of past SARS-CoV-2 transmission using the data from this test when applied to samples from a single cross-sectional sero-prevalence survey.Keywords
This publication has 32 references indexed in Scilit:
- Seroprevalence of anti-SARS-CoV-2 IgG antibodies among truck drivers and assistants in KenyaPublished by Cold Spring Harbor Laboratory ,2021
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infectionScience, 2021
- An action plan for pan-European defence against new SARS-CoV-2 variantsThe Lancet, 2021
- Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcomeScience Immunology, 2020
- Declining prevalence of antibody positivity to SARS-CoV-2: a community study of 365,000 adultsPublished by Cold Spring Harbor Laboratory ,2020
- Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humansNature Microbiology, 2020
- Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillancePublished by Cold Spring Harbor Laboratory ,2020
- Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patientsScience Immunology, 2020
- Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patientsScience Immunology, 2020
- Estimating the burden of SARS-CoV-2 in FranceScience, 2020